drugset / Trial / NCT06504290
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will consist of 2 parts: Part Ⅰ-in healthy adult subjects, Part Ⅱ-in adult patients with schizophrenia
Timeline
- Start
- 2024-07-16
- Primary completion
- 2026-07-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VV119 | Unknown | 0.5 mg | Oral |
| Subject | VV119 | Unknown | 1 mg | Oral |
| Subject | VV119 | Unknown | 2 mg | Oral |
| Subject | VV119 | Unknown | 4 mg | Oral |
| Subject | VV119 | Unknown | 6 mg | Oral |